Please login to the form below

Not currently logged in
Email:
Password:

High Cost Drugs

This page shows the latest High Cost Drugs news and features for those working in and with pharma, biotech and healthcare.

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

GSK, Pfizer and Sanofi among drugmakers planning price hikes in US

The draft guidance would allow states in the US to import prescription drugs from Canada, as part of cost-saving efforts to combat increasing drug prices in the country. ... The Democrats have also launched their  own plans to tackle high drug prices,

Latest news

  • Biologic patent exclusivity scrapped in new US trade deal Biologic patent exclusivity scrapped in new US trade deal

    In the past, the US has pushed to have its exclusivity rules applied to trading partners – in the US, new drugs are afforded 12 years exclusivity for biologics. ... The Democrats also launched their own plans to tackle high drug prices in the US, which

  • Labour party plans to abolish NHS prescription charges Labour party plans to abolish NHS prescription charges

    This in turn, reduces the overall cost to the NHS in England,” she added. ... Under the proposed plan, the federal government would gain the ability to negotiate and cap prices on certain high-cost drugs.

  • Democrats’ final pricing plan announced, 250 drugs targeted Democrats’ final pricing plan announced, 250 drugs targeted

    According to the document, the maximum negotiated price for the 250 high-cost drugs must be no more than 1.2 the average price levied in six index countries – this includes ... This has remained in the final published plan, and means that the federal

  • White House unveils plans to reimport medicines from Canada White House unveils plans to reimport medicines from Canada

    The plan would allow the import of of certain categories of lower cost drugs from Canada, but would exclude all biologic drugs (including insulin), intravenous drugs and controlled substances. ... These limitations would severely restrict the impact of

  • PhRMA opposed to Senate drug price control plans PhRMA opposed to Senate drug price control plans

    But has bipartisan support and Trump backing. Long-awaited Senate Finance Committee proposals to tackle high drug prices through Medicare and Medicaid have been slammed by the trade organisation representing pharma ... The cost of many prescription

More from news
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest Intelligence

  • Risks, reforms and rewards: the evolving Russian healthcare market Risks, reforms and rewards: the evolving Russian healthcare market

    Everyone needs treatment from good doctors, preferably close to where they live, as well as inexpensive and high-quality medicine, but not counterfeit medicine and, of course, regular medical examinations. ... State spending on pharmaceuticals, which

  • Happy 70th birthday NHS: the next 70 need to be very different Happy 70th birthday NHS: the next 70 need to be very different

    However, the increased budget squeeze in England, combined with a wave of new highly-specialised and high-cost drugs is also inevitably causing conflict. ... Perhaps most significant of all is how the government intends to tackle the rising cost of

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Stevens said he believed there was still a need for an overarching UK pricing agreement, such as the PPRS, but NHS England’s role as the gatekeeper for new drugs - especially ... the high cost, specialist medicines emerging from pipelines - is here to

  • Choosing wisely Choosing wisely

    Moreover, where budgets are expanding, it's to cover the cost of essential care rather than pay for high-cost innovative drugs.”. ... Mark. “In China, richer regions are spending more and reimbursing some of the new cancer drugs.

  • Seismic shifts: Hepatitis C and payers Seismic shifts: Hepatitis C and payers

    Prof Boxall's prediction never left my psyche and it's brought to mind whenever difficult decisions about investing public money in high-cost drugs have to be made. ... A European high cost drugs procurement strategy? The threat of an EU-wide procurement

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

  • How does the government plan to reshape the NHS?

    This could help back up clinical trial results and inform industry’s value propositions, particularly around high cost drugs.

  • Integrated NHS finances: what do they mean for High Cost Drugs?

    The CCG will still account for the use of High Cost Drugs, usually via Blueteq. ... For these services, most High Cost Drugs will still be contracted via NHS England.

  • How can pharma engage with Accountable Care Systems?

    medications. If pharma extended this type of monitoring to high cost drugs, especially those that are delivered to patients’ homes and require refrigeration, this would cut waste and improve adherence. ... As a result, cost-based value propositions

  • How will capitated budgets affect NHS spending?

    If the lead provider delivers the desired services more cost effectively than anticipated, any surplus may be invested in further improving services. ... These changes will see more high tech and high cost drugs being administered in the home supported

  • Wilmington Healthcare Wilmington Healthcare

    Integrated NHS finances: what do they mean for High Cost Drugs?. ... Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs.

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
Hybrid working: Insights and tips for success
Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success...
The doctor will text you now: Why healthcare providers cannot underestimate the importance of communicating change
Healthcare communication needs to switch from ‘transmit’ to ‘receive’, listening to what patients need and embracing the plethora of communication tools wholeheartedly....